¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Receptor, IGF Type 2"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
receptor gradient
¼ö¿ë´Ü¹é±â¿ï±â, ¼ö¿ë´Ü¹é°æ»ç, ¼ö¿ëü°æ»ç
receptor imaging
1. ¼ö¿ëü¿µ»ó 2. ¼ö¿ëü¿µ»óÈ
receptor internalization
¼ö¿ëü³»ÀçÈ
receptor potential
¼ö¿ëüÀüÀ§
receptor site
¼ö¿ëüºÎÀ§
receptor stimulant
¼ö¿ëüÀÚ±ØÁ¦
receptor supersensitivity
¼ö¿ëüÃʹΰ¨¼º
receptor-ligand interaction
¼ö¿ëü¸®°£µå»óÈ£ÀÛ¿ë
spare receptor
¿©ºÐ¼ö¿ëü
scavenger receptor
û¼ÒÁ¦¼ö¿ëü
stretch receptor
»¸Ä§¼ö¿ë±â, ½ÅÀå¼ö¿ë±â
sensory receptor
°¨°¢¼ö¿ë±â
silent receptor
¹«¹ÝÀÀ¼ö¿ëü
taste receptor
¹Ì°¢¼ö¿ë±â
T-cell antigen receptor
T¼¼Æ÷Ç׿ø¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
joint receptor
°üÀý¼ö¿ë±â
kinesthetic receptor
¿îµ¿°¨°¢¼ö¿ëü
labyrinthine receptor
¹Ì·Î¼ö¿ëü
muscarinic receptor
¹«½ºÄ«¸°¼ö¿ëü
neuromuscular receptor
½Å°æ±ÙÀ°¼ö¿ëü
nicotinic receptor
´ÏÄÚÆ¾¼ö¿ëü
olfactory receptor
Èİ¢¼ö¿ëü
opiate receptor
¾ÆÆí¼ö¿ëü
opioid receptor
¾ÆÆíÀ¯»ç¹°Áú¼ö¿ëü
paciniform receptor
ÆÄÄ¡´ÏÇü¼ö¿ëü
postsynaptic receptor
¿¬Á¢Èļö¿ëü
prejunctional neuromuscular receptor
½Å°æ±ÙÀ°Á¢ÇÕÀü¼ö¿ëü
pressor receptor
¾Ð·Â¼ö¿ëü
receptor potential
°¨¼ö±âÀüÀ§, °¨¼ö±âÀü¾Ð, ¼ö¿ëüÀü¾Ð
receptor
¼ö¿ëü, ¼ö¿ë±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
hepatitis,type b
B Çü
herpes simplex virus type 1
Á¦1Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
herpes simplex virus type 2
Á¦2Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
htlv,type i
type 1Çü
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperlipoproteinemia type IV
°í´Ü¹éÇ÷Áõ IV Çü
hyperlipoprotenemia type II
°íÁö´Ü¹éÇ÷Áõ II Çü
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,delayed-type
Áö¿¬Çü(òÀæÅû¡)
hypersensitivity reactions,type i(anaphylactic)
IÇü
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
receptor imaging
¼ö¿ëü¿µ»ó(È)
receptor organ
¼ö¿ë±â°ü(áôé»Ðïί).
receptor potential
¼ö¿ë±âÀüÀ§.
receptor sensitivity
¼ö¿ëü °¨¼ö¼º
receptor site
¼ö¿ëüºÎÀ§.
receptor stimulants
¼ö¿ëüÀÚ±ØÁ¦.
receptor supersensitivity
¼ö¿ëü Ãʰ¨¼ö¼º(áôéÄô÷ õ±Êïáôàõ)
receptor, T cell
T¼¼Æ÷(Ç׿ø)¼ö¿ëü
receptor-ligand interaction
¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
retinoic acid receptor
·¹Æ¼³ëÀλê¼ö¿ëü
retinoid acid receptor alpha=RARA
¾ËÆÄ·¹Æ¼³ëÀÍ»ê¼ö¿ëü
secondary receptor
ÀÌÂ÷¼º ¼ö¿ë±â(¡áôé»Ðï).
sensory receptor
°¨°¢¼ö¿ëü.
sigma receptor
½Ã±×¸¶¼ö¿ëü
silent receptor
¹«¹ÝÀÀ¼ö¿ëü.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½